Targeting Natural Killer Cells for Tumor Immunotherapy

Area of Science:

• Immunology
• Cellular Therapy
• Oncology

Background:

• Natural killer (NK) cells are crucial innate immune cells for tumor cell recognition and elimination.
• Adoptive transfer of activated NK cells is a developing cancer therapy, effective in hematologic cancers but limited in solid tumors.
• Solid tumors present significant barriers to NK cell efficacy, including impaired trafficking, infiltration, and function within the tumor microenvironment.

Purpose of the Study:

• To review the impact of the tumor microenvironment on NK cell functions.
• To summarize current and emerging immunotherapeutic strategies utilizing NK cells for cancer treatment.
• To highlight advancements in overcoming tumor microenvironment-mediated suppression for improved solid tumor immunotherapy outcomes.

Main Methods:

• Review of existing literature on NK cell biology and cancer immunotherapy.
• Analysis of strategies to enhance NK cell persistence, activation, and cytolytic activity.
• Discussion of methods to counteract tumor microenvironment-induced NK cell dysfunction and exhaustion.

Main Results:

• The tumor microenvironment significantly impairs NK cell trafficking, function, and survival, leading to exhaustion.
• Various strategies, including cytokine activation, CAR modification, and checkpoint blockade, aim to enhance NK cell anti-tumor activity.
• Recent advances focus on overcoming the suppressive tumor milieu to improve NK cell-based therapy efficacy in solid tumors.

Conclusions:

• NK cell-based immunotherapy holds potential for solid tumors, but overcoming the suppressive tumor microenvironment is critical.
• Continued research into modifying NK cells and their interaction with the tumor microenvironment is essential for therapeutic success.
• Developing strategies to enhance NK cell function and persistence will improve clinical outcomes in solid tumor treatment.